BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12559596)

  • 1. Signify ER Drug Screen Test evaluation: comparison to Triage Drug of Abuse Panel plus tricyclic antidepressants.
    Phillips JE; Bogema S; Fu P; Furmaga W; Wu AH; Zic V; Hammett-Stabler C
    Clin Chim Acta; 2003 Feb; 328(1-2):31-8. PubMed ID: 12559596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
    Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
    J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
    Peace MR; Tarnai LD; Poklis A
    J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays.
    Begeman A; Franssen EJF
    Ther Drug Monit; 2018 Feb; 40(1):135-139. PubMed ID: 29194289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine levels of drugs for which Triage DOA screening was positive.
    Moriya F
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S434-6. PubMed ID: 19261513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of DRIVEN-FLOW® M7-II, a new on-site drug screening kit in postmortem urine compared with Triage DOA®.
    Tanaka T; Yoshizumi S; Kasai K; Yoshida K; Sato H
    Leg Med (Tokyo); 2021 Feb; 48():101804. PubMed ID: 33152676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary comparative study on the usefulness of instant-view'TM M-1 and Triage DOA in testing for drugs-of-abuse in forensic urine samples].
    Moriya F
    Chudoku Kenkyu; 2012 Sep; 25(3):243-6. PubMed ID: 23057404
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of the novel immunoassay TRIAGE to a rapid detection of antemortem drug abuse.
    Röhrich J; Schmidt K; Bratzke H
    J Anal Toxicol; 1994; 18(7):407-14. PubMed ID: 7861755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.
    Moody DE; Fang WB; Andrenyak DM; Monti KM; Jones C
    J Anal Toxicol; 2006; 30(1):50-6. PubMed ID: 16620532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a colloidal metal immunoassay device for the detection of tricyclic antidepressants in urine.
    Poklis A; Edinboro LE; Lee JS; Crooks CR
    J Toxicol Clin Toxicol; 1997; 35(1):77-82. PubMed ID: 9022656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.
    Poklis A; Poklis JL; Tarnai LD; Backer RC
    J Anal Toxicol; 2004 Sep; 28(6):485-8. PubMed ID: 15516300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
    Krasowski MD; Pizon AF; Siam MG; Giannoutsos S; Iyer M; Ekins S
    BMC Emerg Med; 2009 Apr; 9():5. PubMed ID: 19400959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
    Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
    J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A field evaluation of five on-site drug-testing devices.
    Crouch DJ; Hersch RK; Cook RF; Frank JF; Walsh JM
    J Anal Toxicol; 2002 Oct; 26(7):493-9. PubMed ID: 12423006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytic performance of immunoassays for drugs of abuse below established cutoff values.
    Luzzi VI; Saunders AN; Koenig JW; Turk J; Lo SF; Garg UC; Dietzen DJ
    Clin Chem; 2004 Apr; 50(4):717-22. PubMed ID: 14764642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups.
    Lin CN; Nelson GJ; McMillin GA
    J Anal Toxicol; 2013; 37(1):30-6. PubMed ID: 23144203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multianalyte assay system developed for drugs of abuse.
    Parsons RG; Kowal R; LeBlond D; Yue VT; Neargarder L; Bond L; Garcia D; Slater D; Rogers P
    Clin Chem; 1993 Sep; 39(9):1899-903. PubMed ID: 8375068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity.
    Tomaszewski C; Runge J; Gibbs M; Colucciello S; Price M
    J Emerg Med; 2005 May; 28(4):389-94. PubMed ID: 15837018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.